Similarly, comparison of eQTL/GWAS-linked gene pathways in EA cases vs GAIN controls also highlighted C3 and C5 complement and coagulation pathway activation, allograft rejection, autoimmune, interferon signaling and antigen presentation and Class II MHC pathways (Figure 5B). Here, C5 is linked to Esophageal atresia.